- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有157家主力机构披露2025-06-30报告期持股数据，持仓量总计2.18亿股，占流通A股68.54%
- 波段诊断：
-
技术面诊股
诊断结果：6.5技术面打败了47%的股票
技术面评分前10的股票
近期的平均成本为34.40元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为34.40元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"34.40","date":1763285166,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.11.17","stock":"-1.38","trade":null,"ind":"-0.46"},{"date":"2025.11.14","stock":"-0.94","trade":null,"ind":"-0.97"},{"date":"2025.11.13","stock":"0.11","trade":null,"ind":"0.73"},{"date":"2025.11.12","stock":"-0.51","trade":null,"ind":"-0.07"},{"date":"2025.11.11","stock":"1.61","trade":null,"ind":"-0.39"},{"date":"2025.11.10","stock":"0.49","trade":null,"ind":"0.53"},{"date":"2025.11.07","stock":"-1.90","trade":null,"ind":"-0.25"},{"date":"2025.11.06","stock":"0.17","trade":null,"ind":"0.97"},{"date":"2025.11.05","stock":"0.77","trade":null,"ind":"0.23"},{"date":"2025.11.04","stock":"-0.34","trade":null,"ind":"-0.41"},{"date":"2025.11.03","stock":"0.75","trade":null,"ind":"0.55"},{"date":"2025.10.31","stock":"1.90","trade":null,"ind":"-0.81"},{"date":"2025.10.30","stock":"0.53","trade":null,"ind":"-0.73"},{"date":"2025.10.29","stock":"0.06","trade":null,"ind":"0.70"},{"date":"2025.10.28","stock":"0.53","trade":null,"ind":"-0.22"},{"date":"2025.10.27","stock":"-0.35","trade":null,"ind":"1.18"},{"date":"2025.10.24","stock":"-0.38","trade":null,"ind":"0.71"},{"date":"2025.10.23","stock":"-0.50","trade":null,"ind":"0.22"},{"date":"2025.10.22","stock":"0.65","trade":null,"ind":"-0.07"},{"date":"2025.10.21","stock":"-0.15","trade":null,"ind":"1.36"},{"date":"2025.10.20","stock":"2.59","trade":null,"ind":"0.63"}]
海尔生物,上证指数,医疗器械指数
压力支撑
该股压力位为34.48元，支撑位为34.02元。
[{"text":"\u538b\u529b\u4f4d","value":"34.48","date":1763308800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"34.02","date":1763308800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：5.5资金面打败了74%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：11月17日 18:16
| 机构今日流向(万元) | -1943.44 | 机构5日流向(万元) | -2860.52 |
| 机构10日流向(万元) | -5818.07 | 机构20日流向(万元) | -11414.35 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加256.51万股，其中基金净减仓24家，主力净增仓18家，请投资者中长期谨慎为宜。
截止2025-06-30，共157家主力机构（基金148家，一般法人8家，QFII1家），持仓量总计21791.93万股，占流通A股68.54%
其中，基金持仓与2024-12-31相比：
增仓：22家 ，增持 119.32万股
减仓：46家 ，减持 294.96万股
新出现在主力名单中：68家 ，持有1700.46万股
从主力名单中消失：50家 ，原持有1491.05万股
其中，基金持仓与2024-12-31相比：
增仓：22家 ，增持 119.32万股
减仓：46家 ，减持 294.96万股
新出现在主力名单中：68家 ，持有1700.46万股
从主力名单中消失：50家 ，原持有1491.05万股
消息面诊股
诊断结果：5.5消息面打败了82%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 海尔生物：11月14日获融资买入1241.96万元
2025-11-15 - 海尔生物：11月13日获融资买入2108.63万元
2025-11-14 - 从科技到产品！海尔生物医疗的“进博绿”，藏着哪些硬
2025-11-13 - 国内首破的十万转超高速离心机技术，到底有多牛？
2025-11-13 - 海尔生物：11月12日获融资买入3044.55万元
2025-11-13 - 海尔生物：11月11日获融资买入2670.52万元
2025-11-12 - 海尔生物：刘占杰先生担任公司第三届董事会职工代表董
2025-11-11 - 海尔生物（截止2025年11月10日）股东人数为1
2025-11-11 - 海尔生物：围绕药房和手术室智能管理 已形成用药自动
2025-11-11 - 海尔生物：除董事会任职变动外，其他任职没有变动
2025-11-11
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-31 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-31 |
| 一般消息 | 高管变动 | 内部工作调整 | 2025-10-29 |
| 一般消息 | 募资投向 | 2025-09-22 | |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-27 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派4.7元(含税) | 2025-03-29 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-29 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-01-07 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 一般消息 | 高管变动 | 因个人年龄原因从公司正式退休 | 2024-12-02 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了11%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2025.11.17","price":"-0.46","value":null},{"date":"2025.11.14","price":"-0.97","value":null},{"date":"2025.11.13","price":"0.73","value":null},{"date":"2025.11.12","price":"-0.07","value":null},{"date":"2025.11.11","price":"-0.39","value":null},{"date":"2025.11.10","price":"0.53","value":null},{"date":"2025.11.07","price":"-0.25","value":null},{"date":"2025.11.06","price":"0.97","value":null},{"date":"2025.11.05","price":"0.23","value":null},{"date":"2025.11.04","price":"-0.41","value":null},{"date":"2025.11.03","price":"0.55","value":null},{"date":"2025.10.31","price":"-0.81","value":null},{"date":"2025.10.30","price":"-0.73","value":null},{"date":"2025.10.29","price":"0.70","value":null},{"date":"2025.10.28","price":"-0.22","value":null},{"date":"2025.10.27","price":"1.18","value":null},{"date":"2025.10.24","price":"0.71","value":null},{"date":"2025.10.23","price":"0.22","value":null},{"date":"2025.10.22","price":"-0.07","value":null},{"date":"2025.10.21","price":"1.36","value":null},{"date":"2025.10.20","price":"0.63","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 天益医疗 | 36.45% | 0.22% | 5.8分 |
| 2 | 华兰股份 | 30.69% | 8.34% | 5.8分 |
| 3 | 济高发展 | 25.41% | 9.07% | 4.4分 |
| 4 | 利德曼 | 22.68% | 19.05% | 5.8分 |
| 5 | 奥美医疗 | 22.27% | -6.07% | 5.8分 |
| 6 | 康为世纪 | 21.89% | 14.16% | 5.8分 |
| 8 | 理邦仪器 | 19.15% | 1.30% | 6.2分 |
| 10 | 中源协和 | 15.11% | 2.99% | 5.4分 |
| 12 | 微电生理 | 13.21% | -4.84% | 4.7分 |
| 14 | 浩欧博 | 13.01% | 3.35% | 5.4分 |
| 16 | 英诺特 | 12.27% | 0.52% | 5.0分 |
| 18 | 振德医疗 | 11.40% | -11.20% | 5.2分 |
| 20 | 凯普生物 | 10.55% | 3.17% | 5.7分 |
| 22 | 黄山胶囊 | 9.97% | 3.79% | 6.5分 |
| 24 | 达安基因 | 9.70% | 2.83% | 6.0分 |
| 26 | 正川股份 | 9.53% | 5.53% | 5.0分 |
| 28 | 三鑫医疗 | 9.10% | 1.22% | 5.3分 |
| 30 | 爱威科技 | 8.26% | -1.72% | 5.8分 |
| 32 | 威高血净 | 8.24% | -5.07% | 5.8分 |
| 34 | 东方海洋 | 8.02% | 7.60% | 5.4分 |
| 36 | 港通医疗 | 7.76% | 2.16% | 5.6分 |
| 38 | 科华生物 | 7.59% | 2.96% | 5.7分 |
| 40 | 正海生物 | 6.36% | 0.67% | 5.2分 |
| 42 | 济民健康 | 6.14% | 9.39% | 5.0分 |
| 44 | 奥泰生物 | 5.98% | 0.80% | 5.9分 |
| 46 | 冠昊生物 | 5.31% | 1.29% | 6.1分 |
| 48 | 美康生物 | 5.21% | 2.15% | 5.3分 |
| 50 | 中红医疗 | 4.86% | 3.24% | 6.1分 |
| 52 | 欧普康视 | 4.80% | -0.65% | 5.6分 |
| 54 | ST凯利 | 4.66% | 4.84% | 5.7分 |
| 56 | - | 4.42% | -3.32% | 分 |
| 58 | 维力医疗 | 4.30% | -1.26% | 5.6分 |
| 60 | 澳华内镜 | 3.70% | -3.77% | 5.4分 |
| 62 | 九强生物 | 3.64% | -1.16% | 5.3分 |
| 64 | 东星医疗 | 3.09% | 3.13% | 5.7分 |
| 66 | 艾德生物 | 3.01% | 0.34% | 5.4分 |
| 68 | 蓝帆医疗 | 2.99% | 1.92% | 5.6分 |
| 70 | 尚荣医疗 | 2.74% | 1.98% | 5.5分 |
| 72 | 祥生医疗 | 2.32% | -4.34% | 5.4分 |
| 74 | 明德生物 | 2.00% | 3.38% | 5.0分 |
| 76 | 普门科技 | 1.88% | 0.07% | 6.1分 |
| 78 | 拱东医疗 | 1.81% | 1.23% | 6.0分 |
| 80 | 超研股份 | 1.61% | -0.97% | 4.8分 |
| 82 | - | 1.43% | -3.89% | 分 |
| 84 | 健尔康 | 1.36% | -0.70% | 5.2分 |
| 86 | 海利生物 | 1.15% | 0.14% | 5.5分 |
| 88 | 山东药玻 | 1.00% | -0.42% | 5.7分 |
| 90 | - | 0.82% | -3.90% | 分 |
| 92 | 安图生物 | 0.08% | -2.20% | 5.5分 |
| 94 | - | -0.12% | -0.43% | 分 |
| 96 | 瑞迈特 | -1.66% | -6.30% | 5.4分 |
| 98 | 春立医疗 | -1.93% | -5.86% | 5.6分 |
| 100 | 康拓医疗 | -2.70% | -1.18% | 5.8分 |
| 102 | 鱼跃医疗 | -2.89% | -1.06% | 5.9分 |
| 104 | 健帆生物 | -2.98% | -1.77% | 5.1分 |
| 106 | 翔宇医疗 | -3.34% | -1.97% | 4.9分 |
| 108 | 热景生物 | -3.67% | 18.72% | 5.6分 |
| 110 | 万东医疗 | -4.63% | 0.06% | 6.0分 |
| 112 | 联影医疗 | -5.00% | -5.48% | 5.0分 |
| 114 | 华大智造 | -5.45% | -1.32% | 4.7分 |
| 116 | 南微医学 | -5.69% | -1.07% | 5.4分 |
| 118 | 五洲医疗 | -7.10% | 2.06% | 4.9分 |
| 120 | 大博医疗 | -7.62% | -1.73% | 5.5分 |
| 122 | 乐普医疗 | -7.95% | -4.00% | 4.4分 |
| 124 | 海泰新光 | -8.77% | -2.51% | 5.3分 |
| 126 | 爱朋医疗 | -9.35% | -3.90% | 3.9分 |
| 128 | 开立医疗 | -11.13% | -1.55% | 5.0分 |
| 130 | 惠泰医疗 | -14.51% | -4.46% | 5.8分 |
| 132 | 赛诺医疗 | -30.97% | -1.59% | 5.0分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 60/245 ， 81/245。
[{"date":"2025-09-30","value":"4.56","vol":"2.86"},{"date":"2025-06-30","value":"3.29","vol":"2.27"},{"date":"2025-03-31","value":"2.50","vol":"1.15"},{"date":"2024-12-31","value":"8.52","vol":"0.53"},{"date":"2024-09-30","value":"7.25","vol":"4.71"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.56 | 3.29 | 2.50 | 8.52 | 7.25 |
| 行业(%) | 2.86 | 2.27 | 1.15 | 0.53 | 4.71 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"46.51","vol":"51.79"},{"date":"2025-06-30","value":"46.28","vol":"52.10"},{"date":"2025-03-31","value":"48.35","vol":"51.81"},{"date":"2024-12-31","value":"47.99","vol":"52.63"},{"date":"2024-09-30","value":"48.51","vol":"53.49"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
46.51 | 46.28 | 48.35 | 47.99 | 48.51 |
| 行业(%) | 51.79 | 52.10 | 51.81 | 52.63 | 53.49 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 70/245 ， 85/245。
[{"date":"2025-09-30","value":"-1.17","vol":"-0.61"},{"date":"2025-06-30","value":"-2.27","vol":"-1.71"},{"date":"2025-03-31","value":"0.30","vol":"-0.92"},{"date":"2024-12-31","value":"0.13","vol":"0.64"},{"date":"2024-09-30","value":"-2.43","vol":"0.79"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.17 | -2.27 | 0.30 | 0.13 | -2.43 |
| 行业(%) | -0.61 | -1.71 | -0.92 | 0.64 | 0.79 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-35.83","vol":"-18.69"},{"date":"2025-06-30","value":"-39.09","vol":"-20.27"},{"date":"2025-03-31","value":"-19.88","vol":"-4.25"},{"date":"2024-12-31","value":"-9.71","vol":"-24.11"},{"date":"2024-09-30","value":"-13.45","vol":"-20.23"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-35.83 | -39.09 | -19.88 | -9.71 | -13.45 |
| 行业(%) | -18.69 | -20.27 | -4.25 | -24.11 | -20.23 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 35/245 ， 13/245。
[{"date":"2025-09-30","value":"0.31","vol":"0.25"},{"date":"2025-06-30","value":"0.21","vol":"0.17"},{"date":"2025-03-31","value":"0.12","vol":"0.08"},{"date":"2024-12-31","value":"0.40","vol":"0.35"},{"date":"2024-09-30","value":"0.32","vol":"0.26"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.21 | 0.12 | 0.40 | 0.32 |
| 行业(次) | 0.25 | 0.17 | 0.08 | 0.35 | 0.26 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.89","vol":"1.67"},{"date":"2025-06-30","value":"2.01","vol":"1.13"},{"date":"2025-03-31","value":"1.11","vol":"0.55"},{"date":"2024-12-31","value":"4.08","vol":"2.33"},{"date":"2024-09-30","value":"3.63","vol":"1.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.89 | 2.01 | 1.11 | 4.08 | 3.63 |
| 行业(次) | 1.67 | 1.13 | 0.55 | 2.33 | 1.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"8.31","vol":"14.91"},{"date":"2025-06-30","value":"-0.31","vol":"15.06"},{"date":"2025-03-31","value":"5.40","vol":"4.01"},{"date":"2024-12-31","value":"35.41","vol":"29.57"},{"date":"2024-09-30","value":"9.79","vol":"15.40"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 8.31 | -0.31 | 5.40 | 35.41 | 9.79 |
| 行业 | 14.91 | 15.06 | 4.01 | 29.57 | 15.40 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.08","vol":"1.57"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.04","vol":"2.19"},{"date":"2024-09-30","value":"","vol":"0.01"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.08 | - | 1.04 | - |
| 行业 | 0.00 | 1.57 | 0.00 | 2.19 | 0.01 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/245 ， 36/245。
[{"date":"2025-09-30","value":"2.75","vol":"5.68"},{"date":"2025-06-30","value":"2.91","vol":"5.50"},{"date":"2025-03-31","value":"2.96","vol":"5.89"},{"date":"2024-12-31","value":"2.59","vol":"5.34"},{"date":"2024-09-30","value":"2.80","vol":"5.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.75 | 2.91 | 2.96 | 2.59 | 2.80 |
| 行业 | 5.68 | 5.50 | 5.89 | 5.34 | 5.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.96","vol":"4.56"},{"date":"2025-06-30","value":"2.12","vol":"4.40"},{"date":"2025-03-31","value":"2.28","vol":"4.77"},{"date":"2024-12-31","value":"2.09","vol":"4.32"},{"date":"2024-09-30","value":"2.44","vol":"4.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.96 | 2.12 | 2.28 | 2.09 | 2.44 |
| 行业 | 4.56 | 4.40 | 4.77 | 4.32 | 4.78 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/245 ， 58/245。
[{"date":"2025-09-30","value":"18.85","vol":"22.06"},{"date":"2025-06-30","value":"18.78","vol":"22.01"},{"date":"2025-03-31","value":"19.24","vol":"21.24"},{"date":"2024-12-31","value":"20.20","vol":"21.92"},{"date":"2024-09-30","value":"19.50","vol":"20.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
18.85 | 18.78 | 19.24 | 20.20 | 19.50 |
| 行业(%) | 22.06 | 22.01 | 21.24 | 21.92 | 20.92 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.25","vol":"0.72"},{"date":"2025-06-30","value":"0.24","vol":"0.58"},{"date":"2025-03-31","value":"0.25","vol":"0.57"},{"date":"2024-12-31","value":"0.27","vol":"0.55"},{"date":"2024-09-30","value":"0.26","vol":"0.38"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.25 | 0.24 | 0.25 | 0.27 | 0.26 |
| 行业(%) | 0.72 | 0.58 | 0.57 | 0.55 | 0.38 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"8.45","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"6.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"4.06","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"3.67","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"3.74","blueLineValue":"1.17","type":"YC"}]